Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.0930
+0.0270 (40.86%)
Sep 18, 2025, 3:57 PM EDT
Kelyniam Global Company Description
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.
The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures.
It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007.
Kelyniam Global, Inc. was incorporated in 2005 and is based in Canton, Connecticut.
Kelyniam Global, Inc.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Ross Bjella |
Contact Details
Address: 97 River Road Canton, Nevada 06019 United States | |
| Phone | 800 280 8192 |
| Website | kelyniam.com |
Stock Details
| Ticker Symbol | KLYG |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US4883591004 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Ross Bjella | Chairman and Chief Executive Officer |
| Terrance Kurtenbach | Chief Financial Officer |
| Desiree Webb | Chief Operating and Revenue Officer |
| Michael Hamblett | Director of Investor Relations |
| James Barrow Esq. | General Counsel and Director of Quality and Regulatory |
| Dr. Christopher Mirucki | Chief Medical Officer |